Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > Where is the bottom?

<< Previous

Bullboard Posts

Next >>

Comment by wexworthon Aug 27, 2020 11:35am

164 Views

Post# 31460531

RE:RE:RE:RE:RE:RE:RE:Where is the bottom?

There are all kinds of public companies that are worth billions without any or negligible revenue to support the valuation - why?

Because of two things:

1) they have the intellectual property to control the space, which is particularly important for those technologies that are differentiated and "game changing",

AND (not or)

2) they have access to infrastructure, resources, approvals, and partnerships with global partners who can penetrate the market in the foreseeable future (1-5 years)

EOM

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects